Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $36.7700 (-2.05%) ($34.6100 - $37.8800) on Tue. Nov. 6, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.59% (three month average) | RSI | 46 | Latest Price | $36.7700(-2.05%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 2.9% a day on average for past five trading days. | Weekly Trend | ATRA advances 2.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(58%) ARKG(51%) IBB(50%) IWO(50%) ARKK(48%) | Factors Impacting ATRA price | ATRA will decline at least -1.795% in a week (0% probabilities). VXX(-14%) TLT(-14%) VIXM(-13%) UUP(-12%) UNG(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.795% (StdDev 3.59%) | Hourly BBV | 0 () | Intraday Trend | 0.9% | | | |
|
5 Day Moving Average | $36.73(0.11%) | 10 Day Moving Average | $34.87(5.45%) | 20 Day Moving Average | $35.32(4.11%) | To recent high | -15.5% | To recent low | 16.3% | Market Cap | $2.732b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |